Given the critical function of CD8+ T cells in antitumor immunity, we next depleted CD8+ T cells in vivo by administrating anti-mouse CD8 monoclonal antibodies (mAbs) and subsequently monitoring tumor growth. Here, CD8A is linked to neoplasm.